| product name | structured | CAS No. | purity | annual output |
|---|---|---|---|---|
| Alectinib |  |
CAS No.: 1256580-46-7 | ≥99.0% | 1kg |
| Palbociclib |  |
CAS No.: 571190-30-2 | ≥99.5% | 1kg |
| Lorlatinib |  |
CAS No.: 1454846-35-5 | ≥99.5% | 1kg |
| Pemigatinib |  |
CAS No.: 1513857-77-6 | ≥99.5% | 1kg |
| Rimegepant |  |
CAS No.: 1289023-67-1 | ≥99.5% | 1kg |
| Pralsetinib |  |
CAS No.: 2097132-94-8 | ≥98.0 | 100g |
| product name | structured | CAS No. | purity | annual output |
|---|---|---|---|---|
| Alectinib intermediates I |  |
CAS No.: 1256584-73-2 | ≥98.0 | 500 kg |
| Alectinib intermediates II |  |
CAS No.: 1256584-75-4 | ≥99.0 | 50 kg |
| 4-(piperidin-4-yl)morpholine |  |
CAS No.: 53617-35-9 | ≥99.0 | 100 kg |
| 4-chloro-3-nitrobenzonitrile |  |
CAS No.: 939-80-0 | ≥98.0 | 800 kg |
| 3-tert-Butoxy-3-oxopropanoic acid |  |
CAS No.: 40052-13-9 | ≥97.0 | 500 kg |
| 4-fluoro-2-nitrobenzeneamine |  |
CAS No.: 364-78-3 | ≥98.0 | 2 ton |
| 5-nitroisophthalic acid |  |
CAS No.: 618-88-2 | ≥98.0 | 50 ton |
| Dimethyl 5-nitroisophthalic acid |  |
CAS No.: 13290-96-5 | ≥98.0 | 100 ton |
| 5-aminoisophthalic acid |  |
CAS No.: 99-31-0 | ≥99.0 | 500 ton |
| 2,6-Dichloro-3-nitropyridin-4-amine |  |
CAS No.: 2897-43-0 | ≥98.0 | 50 kg |
| 2-nitro-4-methylsulfonyltoluene |  |
CAS No.: 1671-49-4 | ≥98.0 | 50 kg |
| 3-indoleformic acid |  |
CAS No.: 771-50-6 | ≥98.0 | 100 kg |
| Methyl indole-3- carboxylate |  |
CAS No.: 942-24-5 | ≥98.0 | 100 kg |
| (S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol |  |
CAS No.: 1454847-96-1 | ≥98.0 | 1kg |
| 1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile HCl |  |
CAS No.: 1643141-20-1 | ≥98.0 | 1kg |
| 2,6-difluoro3,5-diMethoxybenzenamine |  |
CAS No.: 651734-54-2 | ≥98.0 | 10kg |
| 4-Chloro-7-azaindole-5-carbaldehyde |  |
CAS No.: 958230-19-8 | ≥98.0 | 10kg |
| (R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-onehydrochloride |  |
CAS No.: 1190363-45-1 | ≥98.0 | 1kg |
| 1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one |  |
CAS No.: 1373116-06-3 | ≥98.0 | 1kg |
| 2,2-Bis(4-hydroxy-3,5-dimethylphenyl)propane |  |
CAS No.: 5613-46-7 | ≥98.0 | 800kg |
| 4,4 \'-Bis(methoxymethyl)-1,1 \'-biphenyl |  |
CAS No.: 3753-18-2 | 97.5% | 800kg |
| 4,4,-Bis(chloromethyl)-1,1,-biphenyl |  |
CAS No.: 1667-10-3 | ≥98.0 | 500kg |
| product name | structured | CAS No. | purity | annual output |
|---|
More
We will attend exhibition API China held in Guangzhou, China during May 26-28, 2021. Booth No. is 13.2B07,
2021-03-02
The Mianyang production base of D+C Pharma has organized and carried out special training to enhance the knowledge of hazardous chemicals of employees.
2020-08-03Developing science and technology to improve human health
The company has a lean R and D team mainly composed of doctors and masters, and will further introduce more talents,
At present, the company can make and supply alectinib, palbociclib, pemigatinib, loratinib, rimegepant and other APIs, including 5-nitroisophthalic acid, 5-aminoisophthalic acid, 2-nitro-4-fluoroaniline, 3-indole-3-carboxylic acid, methyl indole-3-carboxylate, 4-amino-2, 6-dichloropyrimidine, 2-nitro-4-methylsulfonyltoluene and other intermediates.
